²é¿´: 7825  |  »Ø¸´: 46
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

³ÕÃÎäìÏæ

ľ³æ (ÖøÃûдÊÖ)


[½»Á÷] ¹ØÓÚÎÒ²©¿ÍÖÐ×î½ü¼¸ÆªÎÄÕµÄԭʼÊý¾ÝÀ´Ô´ ÒÑÓÐ40È˲ÎÓë

ÍøÓÑÎʵÃÌ«¶à£¬»ã×ܻشð¡£

¹ØÓÚ¹úÄÚÒ©Æ·×¢²áÇé¿ö²éѯ
¹úÄÚ×¢²áÇé¿ö×îȨÍþµÄÊý¾Ý¿âÊÇCFDAÒ©Æ·ÉóÆÀÖÐÐÄ£¨http://www.cde.org.cn/£©£¬ÔÚ¡¾ÐÅÏ¢¹«¿ª¡¿>> ¡¾ÊÕÉóÇé¿ö¡¿Ò»À¸¿ÉÒÔ¼ìË÷£¬µ«¼ìË÷¹¦ÄܱȽϼòª¡£ÎÒÒÔǰÖ÷ÒªÔÚ¶¡ÏãÔ°Ò½Ò©Êý¾Ý¿â£¨http://db.dxy.cn/new/index/start£©²éѯ£¬ÏÖÔÚ¶¡ÏãÔ°Ò²ÒªÊÕ·ÑÁË£¬ËùÒÔ¸ÄÔÚÒ©ÖÇÍøÊý¾Ý¿â£¨http://db.yaozh.com/index.html£©²éѯ£¬½ø¡¾ÆäËûÊý¾Ý¿â¡¿>>¡¾Ò©Æ·×¢²á½ø¶È¡¿¾Í¿ÉÒÔ¼ìË÷ÁË£¬¿ÉÒÔÖ±½ÓÊäÈë×¢²á·ÖÀàÈç1.1¡¢3.1ºÍÈÕÆÚ¼ìË÷ij¸öʱ¼ä¶ÎÉ걨µÄÒ©ÎÊÜÀíºÅµÚ4¸ö×ÖĸÖÐL±íʾ±¨ÁÙ´²¡¢S±íʾ±¨Éú²ú£¬B±íʾ²¹³äÉêÇë¡£ÕâÀïÖ»Äܲ鵽³§¼Ò¡¢×´Ì¬£¬ÖÁÓÚÊÊÓ¦Ö¢°ÐµãµÈÐÅÏ¢ÐèҪͨ¹ýÆäËû·½Ê½»ñµÃ£¬±ÈÈç³§¼Ò¡¢°Ù¶È¡¢Í¬ÐС¢²Â²âµÈ¡£

¹ØÓÚרÀû¼ìË÷
ÎÒÒÔǰ²éרÀûÖ÷ҪȥSooPATרÀû£¨www.soopat.com/Home/Index£©£¬ÏÖÔÚSooPATÒªÊÕ·ÑÁË£¬ËùÒÔ¸ÄÈ¥GoogleרÀû£¨www.google.com/patents£©£¬Å·ÖÞרÀû¾Ö£¨http://www.epo.org/£©Ò²ºÜºÃ£¬µ«ÎÒ²»Ì«Ï°¹ß¡£GoogleרÀûËѵ½ºó£¬ºÜ¶àʱºòÖ±½Ó¾ÍÊÇÈ«ÎÄÔĶÁ£¬Ò²¿ÉÒÔ¹«¸æºÅÖÐÕÒUSרÀûÖ±½ÓÏÂÔØpdf¡£

¹ØÓÚ¡¶suvorexantµÄ¹ÊÊ¡·Ò»ÎÄ
Ô­ÎÄÀ´×ÔThe New YorkerÔÓÖ¾£¨http://www.newyorker.com/reporti ... 31209fa_fact_parker£©£¬×ã×ãдÁË11Ò³£¬Óкܶྫ²ÊµÄϸ½Ú¡¢»ØÒäÒÔ¼°Ò©ÎïÑз¢µÄ»ù´¡ÖªÊ¶£¬ÎÒ½ÚÑ¡ÁËÆäÖеÄÒ»Ð©ÖØµã£¬ÌíÁËһЩרҵÊý¾Ý¡£ÖÁÓÚÎÒΪʲô»á¶Áµ½Õâ¸öÔÓÖ¾ÕâÆªÎÄÕ£¬Ö»ÄÜ˵ÊÇżȻÖеıØÈ»¡£

¹ØÓÚ¡¶¾­¹ýÃÀ¹úFDAÅú×¼µÄÖйúÒ©Æ·»ã×Ü¡·Ò»ÎÄ
Êý¾ÝÖ÷Òª´ÓdrugfutureÍøµÄFDAÊý¾Ý¿â£¨http://www.drugfuture.com/fda/£©¼ìË÷µ½£¬ÕâÀï¿ÉÒÔ°´Ò©Æ·Í¨ÓÃÃû¡¢Ò©Æ·×¢²áÉêÇë»ú¹¹µÈ½øÐи߼¶¼ìË÷£¬µ±È»»¹µÃÒÀÀµÒ»Ð©Ç鱨´¢±¸£¬±ÈÈ绪º£ÔÚÃÀ¹úµÄ·Ö²¿½ÐPrinston£¬º£ÕýµÄÓ¢ÎÄÃû½ÐHisun£¬ÒÔ¼°ÆäËûµÄһЩ×ÊÁÏ¡£

¹ØÓÚ¡¶2014ÄêFDAÐÂÒ©ÉóÅúÈճ̡·Ò»ÎÄ
Ô­Îijö×ÔTheStreetµÄרÀ¸·ÖÎöʦAdam Feuerstein£¨http://www.thestreet.com/story/1 ... ision-calendar.html£©£¬ËûÿÄê¶¼»áдһ¸ö£¬FDA×ÉѯίԱ»áÿÄêµÄ¿ª»áÈÕÆÚÊǹ̶¨µÄ£¬ÕâÔÚAdvisory Committee Calendar£¨http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm£©ÖпÉÒԲ鵽£¬¶øPDUFAÒ²ÊÇ¿ÉÒÔ¼ÆËãµÄ£¨±ê×¼ÉóÆÀ10¸öÔ£¬ÓÅÏÈÉóÆÀ6¸öÔ£©¡£²»¹ýPDUFAÈÕÆÚÓëʵ¼Ê¾ö¶¨ÈÕÆÚ»¹ÊÇÓÐЩ²î±ð£¬±ÈÈçsofosbuvirµÄPDUFAÈÕÆÚÓ¦¸ÃÊÇ12ÔÂ8ÈÕ£¬ÖÁÓÚAdam FeuersteinÊÇÔõôÅжÏsofosbuvirÔÚ12ÔÂ6ÈÕ¾ÍÄÜ»ñÅú£¬ÎÒÒ²²»Ì«Çå³þ¡£

¹ØÓÚ¡¶2002-2013ÄêÖйú´´ÐÂÒ©»ã×Ü¡·¡¢¡¶ÎÒÑÛÖеÄÖйúÐÂÒ©Ñз¢Ê®Ç¿ÆóÒµ¡·Á½ÎÄ
ÆäʵÕâЩÊý¾Ý²éµ½»¹ÊDZȽÏÈÝÒ׵ģ¬Ç°ÃæËù˵µÄÒ©ÖÇÍøÊý¾Ý°´×¢²á·ÖÀàºÍʱ¼ä¶Î¾Í¿ÉÒÔ£¬¾ÍÊDZȽÏÂé·³¶øÇÒûÓаеãÐÅÏ¢¡£ÎÒÊÇÖ±½Ó²Î¿¼ÃÀ¹ú½ðÈÚ¹«Ë¾Morgan Stanley½ñÄê1ÔÂÌṩµÄÖйúÖÆÒ©Ç鱨·ÖÎö±¨¸æ£¨http://www.hysec.com/f/tsnr/[D20 ... 30/201301300451.pdf£©£¬ÖÁÓÚÎÒΪʲô»áÄõ½Õâ¸öÎļþÒ²Ö»ÄÜ˵ÊÇżȻÖеıØÈ»¡£

¹ØÓÚÐÂÒ©ÏúÊÛ¶îÔ¤²â
Õâ¸öÎÒ·´¸´Ìá¹ý£¬Êý¾Ý³ö×ÔEvaluatePharma£¨www.evaluategroup.com£©£¬×¼È·Ô¤²â£¨Îó²îÔÚ40%ÒÔÄÚ£©µÄ¸ÅÂÊΪ40%¡£EvaluatePharma·¢²¼µÄÔ¤²â±¨¸æÊÇÃâ·ÑµÄ£¬µ«ÐèҪע²áÒ»¸öÕ˺ŲÅÄÜÏÂÔØ£¬Èç¹û²»»á×¢²á¡¢²»»áÏÂÔØ£¬ÄÇÕæÊÇÉñÒ²¾È²»ÁËÄã¡£

¹ØÓÚ¸÷ÖÖÁбí
ÎÒ²©¿ÍÖеġ¢ÖйúÐÂÒ©ÔÓ־΢²©Öеĸ÷ÖÖ»ã×ÜÐÔÁÐ±í£¨¹úÍâµÄ£©£¬Î޷dzö×ÔGEN£¨www.genengnews.com£©¡¢Fiercepharma£¨www.fiercepharma.com£©¡¢FirstWordPharma£¨www.firstwordpharma.com£©Èý¸öÍøÕ¾£¬ÖÁÓÚ¾ßÌåÔÚÍøÒ³ÄĸöÀ¸Ä¿Ï£¬²»ÔÙ׸Êö¡£

ºÜ¶àÈ˶ÔÎÒ˵ÊÚÈËÒÔÓã²»ÈçÊÚÈËÒÔÓæ£¬µ«ÊÂÇéÕæµÄûÓÐÏëÏóµÄÄÇô¼òµ¥£¬ÖªµÀÐÅÏ¢À´Ô´²¢²»Òâζ×ÅÄÜÄõ½ÐÅÏ¢£¬Ðí¶à¶«Î÷¶¼ÊÇżȻµÄ£¬Ö»ÓÐÀ©´ó×Ô¼ºµÄ֪ʶ´¢±¸²ÅÄÜ»¯Å¼È»Îª±ØÈ»£¬µ±È»Èç¹ûÓÐÇ®×îºÃÂò¼¸¼ÒרҵÇ鱨»ú¹¹µÄÊý¾Ý¿â£¬¿ÉÒԷdz£·½±ãµØÕƿعúÄÚÍâÒ©ÎïÑз¢ÐÅÏ¢¡£
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yanghuping

ľ³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Â¥Ö÷̫ǿº·ÁË£¬»ù±¾¶¼ÊÇÍâÎĵͼÄÜ¿´µÄºÜÁ÷Àû°¡£¡
30Â¥2013-12-10 13:57:01
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 47 ¸ö»Ø´ð

fxzxp

Ìú¸Ëľ³æ (СÓÐÃûÆø)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
лл£¡

ÉîÓÐͬ¸Ð¡£¡°ÖªµÀÐÅÏ¢À´Ô´²¢²»Òâζ×ÅÄÜÄõ½ÐÅÏ¢¡±£¬´Óº£Á¿ÐÅÏ¢ÖлñÈ¡ÐèÒªµÄÇ鱨£¬µÄÈ·ÐèҪ֪ʶµÄ´¢±¸ºÍרҵѵÁ·¡£ÈκÎÐÅÏ¢Èç¹ûûÓгä·ÖµÄÒÀ¾ÝΪǰÌᣬֻÄÜ×÷ΪÅÔÖ¤²Î¿¼¶øÒÑ¡£

¹úÄڵĹٷ½ÍøÕ¾ËäÈ»²»¶ÏµÄ¼ÓÇ¿¹«¿ª¡¢Í¸Ã÷Á¦¶È£¬µ«ÏÖʵÈÔÊDzîÇ¿ÈËÒâ¡£ÀýÈç¡¶Ò©ÎïÁÙ´²ÊÔÑéµÇ¼ÇºÍÐÅÏ¢¹«Ê¾Æ½Ì¨¡·CFDA¹«¸æ2013ÄêµÚ28ºÅÒªÇ󣺡°¶ÔÒÑ»ñµÃÒ©ÎïÁÙ´²ÊÔÑéÅú¼þÇÒÅú¼þÓÐЧµÄ£¬ÉêÇëÈËÐëÔÚ±¾¹«¸æ·¢²¼Ö®ÈÕÆð3¸öÔÂÄÚÍê³ÉÐÅÏ¢µÇ¼Ç¡±¡£¶ÔÓÚÖ´ÐÐÇé¿ö£¬´ó¼Ò¿ÉÒÔ×Ô¼ºÈ¥¿´¡£ÔÙÈçаæGMPµÄÖ´ÐÐÇé¿ö¿ÉÄÜÒ²ÏàÀàËÆ¡£
2Â¥2013-12-08 14:51:35
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

¹Å¿É¤×

ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)

ÓÅÐãÇø³¤ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ÔÙ¼ÓÒ»¸öhttp://www.citeline.com/products/pharmaprojects/ ²éѯÃÀ¹ú1µ½3ÆÚÁÙ´²µÄ£¬Â¥Ö÷ʱ¼äÕæ¶à£¬È¥µ·¹Ä·­ÒëÕâЩ¶«¶«
·ÇÎáСÌìÏ£¬²Å¸ß¶øÒÑ£»·ÇÎá×ݹŽñ£¬Ê±¸³¶øÒÑ£»·ÇÎáíþ¾ÅÖÝ£¬ºê¹Û¶øÒÑ£»Èý·ÇÑÉ×ÎÞÃÎÖÁʤ
6Â¥2013-12-08 16:20:12
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

³Ë·çÄÁÔÆ

ľ³æ (Ö°Òµ×÷¼Ò)

--

Â¥Ö÷À÷º¦£¬Ä¤°Ý

[ ·¢×ÔСľ³æ¿Í»§¶Ë ]
³Ë³¤·çÒÔÄÁÇàÔÆ
7Â¥2013-12-08 17:28:53
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 07»¯Ñ§280·ÖÇóµ÷¼Á +6 722865 2026-03-23 6/300 2026-03-24 20:58 by allen-yin
[¿¼ÑÐ] 0703»¯Ñ§µ÷¼Á£¬Çóµ¼Ê¦ÊÕ +7 ÌìÌìºÃÔËÀ´Éϰ¶° 2026-03-24 7/350 2026-03-24 20:26 by peike
[¿¼ÑÐ] Çóµ÷¼Á323²ÄÁÏÓ뻯¹¤ +3 1124361 2026-03-24 3/150 2026-03-24 20:24 by peike
[¿¼ÑÐ] ¡¾¿¼Ñе÷¼Á¡¿»¯Ñ§×¨Òµ 281·Ö£¬Ò»Ö¾Ô¸ËÄ´¨´óѧ£¬³ÏÐÄÇóµ÷¼Á +15 ³Ô³Ô³Ô²ÅÓÐÒâÒå 2026-03-19 16/800 2026-03-24 19:51 by ÁËÁËÁËÁË¡£¡£
[¿¼ÑÐ] ²ÄÁÏר˶ÕÒµ÷¼Á +5 ¹þ¹þ¹þºðºðºð¹þ 2026-03-23 5/250 2026-03-24 19:07 by ÁËÁËÁËÁË¡£¡£
[¿¼ÑÐ] 306Çó0703µ÷¼ÁÒ»Ö¾Ô¸»ªÖÐʦ·¶ +10 Ö½Óãly 2026-03-21 11/550 2026-03-24 17:22 by qingfeng258
[¿¼ÑÐ] Ò»Ö¾Ô¸211 ³õÊÔ270·Ö Çóµ÷¼Á +5 ¹ÈÓêÉϰ¶ 2026-03-23 6/300 2026-03-24 16:32 by laoshidan
[¿¼ÑÐ] 307Çóµ÷¼Á +5 ³¬¼¶ÒÁ°º´óÍõ 2026-03-24 5/250 2026-03-24 15:46 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] 336»¯¹¤µ÷¼Á +4 Íõ´ó̹1 2026-03-23 5/250 2026-03-23 18:32 by allen-yin
[ÂÛÎÄͶ¸å] ¼±·¢ºËÐÄÆÚ¿¯ÂÛÎÄ +3 ÏÍ´ïÎʽò 2026-03-23 5/250 2026-03-23 17:13 by ÃÃ×Ó²»ºÃÈÇ
[¿¼ÑÐ] 328Çóµ÷¼Á +4 LHHL66 2026-03-23 4/200 2026-03-23 14:55 by lbsjt
[¿¼ÑÐ] 298Çóµ÷¼Á +8 Éϰ¶6666@ 2026-03-20 8/400 2026-03-23 11:02 by laoshidan
[¿¼ÑÐ] Ò»Ö¾Ô¸¶«»ª´óѧ»¯Ñ§070300£¬Çóµ÷¼Á +7 2117205181 2026-03-21 8/400 2026-03-22 22:55 by chixmc
[¿¼ÑÐ] Çóµ÷¼Á +5 Zhangbod 2026-03-21 7/350 2026-03-22 13:13 by Zhangbod
[¿¼ÑÐ] 303Çóµ÷¼Á +5 °²ÒäÁé 2026-03-22 6/300 2026-03-22 12:46 by ËØÑÕÇã³Ç1988
[¿¼ÑÐ] 354Çóµ÷¼Á +7 Tyoumou 2026-03-18 10/500 2026-03-22 11:11 by ÈËÀ´Ê¢
[¿¼ÑÐ] ²ÄÁÏѧ˶301·ÖÇóµ÷¼Á +7 Liyouyumairs 2026-03-21 7/350 2026-03-21 22:31 by peike
[¿¼ÑÐ] 297Çóµ÷¼Á +3 ϲ»¶»¹ÊDz»¸ÊÐÄ 2026-03-20 3/150 2026-03-21 18:33 by ѧԱ8dgXkO
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷ÄϽ»´ó£¬Çóµ÷¼Á +5 ²Ä»¯ÖðÃÎÈË 2026-03-18 5/250 2026-03-21 00:26 by JourneyLucky
[¿¼ÑÐ] ÖÐÄÏ´óѧ»¯Ñ§Ñ§Ë¶337Çóµ÷¼Á +3 niko- 2026-03-19 6/300 2026-03-20 21:58 by luoyongfeng
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û